| Name | CRA-2059 |
|---|
| Description | CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1]. |
| References |
| Molecular Formula | C34H46N12O8 |
|---|---|
| Molecular Weight | 750.80 |